table in Medical Technology
Navigation Links
table in Medical Technology
...s were observed in the three higher dose cohorts (50, 75 and 100 mg/day). Post-treatment viral load data suggest no evidence of drug accumulation. The table below summarizes mean HCV RNA reductions observed in this study per cohort:
End of Treatment Mean Patients w...
.... Registration Trial Number: NCT00125918. Page 31, table 2. (6)Galie, N., et al. "Tadalafil therapy for p.... Registration Trial Number: NCT00125918. Page 31, table 2. (9)Galie, N., et al. "Tadalafil therapy for p.... Registration Trial Number: NCT00125918. Page 32, table 2. (10)Galie, N., et al. "Tadalafil therapy for ...
...rt failure (CHF). The total cumulative doxorubicin equivalent exposure per treatment cycle for all 68 patients treated with pixantrone is noted in the table below: Treatment Cycle No. of Patients Pixantrone Lifetime Treatment...
...-week treatment period. The results for each study were analyzed using both life-table and crude-rate statistical methods. Results are listed in the table below: REDUCE 1 (n=812) REDUCE 2 (n=570) HZT-501 Ibuprofen P-value HZT-501 Ibuprofen P-...
...sion or recurrence in some clinical studies in patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers (see WARNINGS: table 1). To decrease these risks, as well as the risk of serious cardio- and thrombovascular events, use the lowest dose needed to avoid red bloo...
...oonotic diseases, the FAZD Center announced today. Among those innovations: A "Doc in a Box" on every American kitchen table that detects highly contagious and dangerous zoonotic diseases in people before symptoms appear. Computer-generated "lab animals" that increas...
...currence in some clinical studies in patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers (see WARNINGS: table 1). -- To decrease these risks, as well as the risk of serious cardio- and thrombovascular events, use the lowest dose needed to avoid red bl...
...ary health statistics for U.S. adults: National Health Interview Survey, 2003. National Center for Health Statistics. Vital Health Stat 10(225). 2005. table 3. ...
...qual to about 7 ounces, slightly less than 1 cup), brewing for 5 minutes before consumption. Subjects consumed the rooibos with or without milk and/or table sugar, as previous research on green and black teas (from the tea plant, Camellia sinensis) have demonstrated that milk does not eliminate the increas...
... equal to 20% of patients in CellCept group in controlled studies in prevention of renal, cardiac or hepatic allograft rejection are listed in table 8 of the ADVERSE REACTIONS section of the complete Prescribing Information. About Roche Hoffmann-La Roche Inc. (Roche), based in Nutley, N....
...led events that were reported in greater than or equal to studies in prevention of renal, cardiac or hepatic allograft rejection are listed in table 8 of the ADVERSE REACTIONS section of the complete Prescribing Information. About Roche Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J.,...
...he results for each study were analyzed using life table and crude rate methods. Results from these trial...rates for patients with EE. In one study, the life table analysis showed that 93 percent and 95 percent of ...zole 30 mg patients. In a second study, the life table analysis demonstrated that 92 percent of both 60 m...
...titis C virus (HCV) genotype 1 infection. InterMune reported that treatment with ITMN-191 resulted in rapid and significant reductions in HCV RNA (see table below). Total Daily Mean Maximum Reduction Cohort Dose Dose (mg) HCV RNA Log10 IU/mL (range) ...
...rug-related side effects (incidence . 5% in at least one drug dose group) reported across the three drug dose groups and placebo are listed in the table below. Placebo 1.25 mg 2.5 mg 5 mg Side Effects (%) (%) (%) ...
...a show that this superior survival benefit for Genasense-treated patients extends to all patients who achieved CR/nPR. These data are presented in the table below. Survival Genasense/Flu/Cy Flu/Cy p-value 1 year 20 8 ...
...ghest plasma drug levels (400 mg modified-release capsule twice daily), there was a 50.9% placebo-adjusted reduction in SUA (p < 0.001). The following table summarizes the results by dose group. Effect of RDEA806 on Serum Uric Acid (SUA) Levels in Phase 1 MAD Study ...
...afety and efficacy profile," concluded Dr. Jonas. table 1: Mipomersen in Routine High Cholesterol Patients...ersus a pooled placebo from all cohorts (n=14) table 2: Mipomersen Phase 1 and Phase 2 Summary of On-Tr... ALT reading *** ULN is defined to be 50 IU/L table 3: Mipomersen Phase 1 and Phase 2 Summary of Entir...
...d learn from each others' experiences in a secure online environment. "I love the technology, because it brings people from all over the world to the table to solve real-world problems in real time," said Richard Guyer, M.D., co-founder and fellowship director of the Texas Back Institute and a principal i...
... the upper limit of normal. Efficacy results in this group of 274 patients, which are the focus of the confirmatory AGENDA trial, are displayed in the table below. (The hazard ratios indicate that the addition of Genasense to DTIC was associated with a 42% reduction in the risk of disease progression and a...
...results from the study will be presented in the future, as will data from the ongoing double-blind, placebo-controlled heterozygous FH study. table 1: ISIS 301012 in HoFH, Summary of Results Lipid values are presented in mg/dL and % change from baseline. Patient 1 ...
... 300 mg/week) than the 300 mg/week cohort. table 1: ISIS 301012 Coadministered with Statins, Summa...nalysis was 30 days post last dose, Day 59 table 2: ISIS 301012 Coadministered with Statins, Absol...nalysis was 30 days post last dose, Day 59 table 3: ISIS 301012 Coadministered with Statins, Patie...
...r 12 weeks of treatment, and SVR, defined as undetectable HCV RNA 24 weeks after the end of 48 weeks of treatment. Response rates are presented in the table below: HCV RNA Results Omega IFN + RBV Omega IFN Alone (LOQ= 50 IU/ml) N=67 N...
Spherix Announces Positive Phase 2 Study Results
...naturally in small amounts in dairy products. It is a highly soluble white crystal or powder, can be produced with a physical bulk similar to ordinary table sugar, and is 92% as sweet. In the U.S., based on over 10 years of animal, human, and other relevant use and safety data, Naturlose was determined to ....... Registration Trial Number: NCT00125918. Page 31, table 2. (6)Galie, N., et al. "Tadalafil therapy for p.... Registration Trial Number: NCT00125918. Page 31, table 2. (9)Galie, N., et al. "Tadalafil therapy for p.... Registration Trial Number: NCT00125918. Page 32, table 2. (10)Galie, N., et al. "Tadalafil therapy for ...
...rt failure (CHF). The total cumulative doxorubicin equivalent exposure per treatment cycle for all 68 patients treated with pixantrone is noted in the table below: Treatment Cycle No. of Patients Pixantrone Lifetime Treatment...
...-week treatment period. The results for each study were analyzed using both life-table and crude-rate statistical methods. Results are listed in the table below: REDUCE 1 (n=812) REDUCE 2 (n=570) HZT-501 Ibuprofen P-value HZT-501 Ibuprofen P-...
Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997
... trial report, including a complete list of adverse events and the recommended dose for Phase II studies, within three months. The following table provides a summary of the key aspects of this trial. ------------------------------------------------------------------------- Name of Trial ......sion or recurrence in some clinical studies in patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers (see WARNINGS: table 1). To decrease these risks, as well as the risk of serious cardio- and thrombovascular events, use the lowest dose needed to avoid red bloo...
...oonotic diseases, the FAZD Center announced today. Among those innovations: A "Doc in a Box" on every American kitchen table that detects highly contagious and dangerous zoonotic diseases in people before symptoms appear. Computer-generated "lab animals" that increas...
...currence in some clinical studies in patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers (see WARNINGS: table 1). -- To decrease these risks, as well as the risk of serious cardio- and thrombovascular events, use the lowest dose needed to avoid red bl...
Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds
... research needs to be done. The researchers studied the effect of regular table grapes (a blend of green, red, and black grapes) that were mixed into the r...en to reduce mild high blood pressure without medication. The dose of whole table grape powder that was consumed in the study was roughly equivalent to a per......ary health statistics for U.S. adults: National Health Interview Survey, 2003. National Center for Health Statistics. Vital Health Stat 10(225). 2005. table 3. ...
...qual to about 7 ounces, slightly less than 1 cup), brewing for 5 minutes before consumption. Subjects consumed the rooibos with or without milk and/or table sugar, as previous research on green and black teas (from the tea plant, Camellia sinensis) have demonstrated that milk does not eliminate the increas...
Cytopia Commences Second Phase II Study in Brain Cancer
...wn abnormal blood supply for growth, rendering them potentially susceptible to destruction by an anti-vascular agent such as CYT997. The following table provides a summary of the key aspects of the Phase II GBM trial. Name of trial A Phase Ib/II Study of CYT997 in Combination with ...Amicus Therapeutics Announces Second Quarter 2008 Financial Results
... (617) 897-8294 Source: FOLD -G table 1 Amicus Therapeutics, Inc....7,083,748 22,467,198 4,051,709 22,439,893 table 2 Amicus Therapeutics, Inc....467,198 22,467,198 table 3 Amicus Therapeutics, Inc....... equal to 20% of patients in CellCept group in controlled studies in prevention of renal, cardiac or hepatic allograft rejection are listed in table 8 of the ADVERSE REACTIONS section of the complete Prescribing Information. About Roche Hoffmann-La Roche Inc. (Roche), based in Nutley, N....
...led events that were reported in greater than or equal to studies in prevention of renal, cardiac or hepatic allograft rejection are listed in table 8 of the ADVERSE REACTIONS section of the complete Prescribing Information. About Roche Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J.,...
AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
...of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. American Journal of Gastroenterology 2003;98(7):1494-1499. table 5. (9) Mose et al. Thirty-day mortality after peptic ulcer bleeding in hospitalized patients receiving low-dose aspirin at time of admis...New Pharma Business Model Increases Pressure on Staff Communicating Trial Data
...uster: Best Practices in Communicating Clinical Trial Results." Download the complimentary research summary of this benchmarking study including the table of contents, sample best practices and data charts at http://www3.best-in-class.com/rr948.htm . The report presents the lessons learned and best pr......he results for each study were analyzed using life table and crude rate methods. Results from these trial...rates for patients with EE. In one study, the life table analysis showed that 93 percent and 95 percent of ...zole 30 mg patients. In a second study, the life table analysis demonstrated that 92 percent of both 60 m...
Phosphagenics Reports Positive Pre-clinical Results for Targeted Delivery of Lidocaine
...r topical application of TPM/Lidocaine, compared to Xylocaine(R) alone (see table 1). In addition, TPM/Lidocaine was able to increase the depth of lidocain...2.23 0.59 +/- 0.10 77.46 +/- 38.38 table 1 Dr. Esra Ogru, Executive Vice President of Research and Development at ...InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
...ished data describing other HCV protease inhibitors. The additional information pertains to the Day 14 median reductions in HCV RNA in this study (see table below). Mean Maximum Reduction Day 14 Median ......titis C virus (HCV) genotype 1 infection. InterMune reported that treatment with ITMN-191 resulted in rapid and significant reductions in HCV RNA (see table below). Total Daily Mean Maximum Reduction Cohort Dose Dose (mg) HCV RNA Log10 IU/mL (range) ...
...rug-related side effects (incidence . 5% in at least one drug dose group) reported across the three drug dose groups and placebo are listed in the table below. Placebo 1.25 mg 2.5 mg 5 mg Side Effects (%) (%) (%) ...
ORTHO EVRA(R) Prescribing Information Updated
...relative risk for VTE of 0.9 (indicating no increase in risk) and 2.4 (indicating an approximate doubling of risk). This information is presented in a table in the WARNINGS section and is available at http://www.fda.gov and http://www.orthoevra.com . The results from all of these epidemiologic studies c...US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
...indicated that 185 patients with a median age of 50 years (range, 24-84) were treated; 179 underwent definitive surgery. Results are summarized in the table below: Subset Number of Patients Percentage pCR Breast/A...Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
...of 21) who had their dose reduced, successfully completed the clinical trial with minimal safety issues. The key safety results are shown in the table below: Placebo 50mg 100mg 150mg po BID N=47 po BID N=46 po BID N=49 po BID......a show that this superior survival benefit for Genasense-treated patients extends to all patients who achieved CR/nPR. These data are presented in the table below. Survival Genasense/Flu/Cy Flu/Cy p-value 1 year 20 8 ...
...ghest plasma drug levels (400 mg modified-release capsule twice daily), there was a 50.9% placebo-adjusted reduction in SUA (p < 0.001). The following table summarizes the results by dose group. Effect of RDEA806 on Serum Uric Acid (SUA) Levels in Phase 1 MAD Study ...
...afety and efficacy profile," concluded Dr. Jonas. table 1: Mipomersen in Routine High Cholesterol Patients...ersus a pooled placebo from all cohorts (n=14) table 2: Mipomersen Phase 1 and Phase 2 Summary of On-Tr... ALT reading *** ULN is defined to be 50 IU/L table 3: Mipomersen Phase 1 and Phase 2 Summary of Entir...
Isis Reports Positive Results of Phase 2 Study of ISIS 301012 in Heterozygous FH Patients
... beyond the levels they had already achieved on stable lipid-lowering therapies. ISIS 301012 treatment did not affect HDL-cholesterol (HDL-C) levels. table 1: ISIS 301012 in HeFH Patients on Maximally Tolerated Lipid-Lowering Therapies, Summary of Results. Median % changes from baseline at primary endpoi...Beaumont Patients 1st to get Next Generation of Radiation Treatment
...to moment. Omnibeam(R) also uses robotic technology to adjust the treatment table on which a patient lies to provide pinpoint accuracy of treatment. Adjusting the radiation field and treatment table means the radiation treatment is precisely targeted to kill cancer cells, d......d learn from each others' experiences in a secure online environment. "I love the technology, because it brings people from all over the world to the table to solve real-world problems in real time," said Richard Guyer, M.D., co-founder and fellowship director of the Texas Back Institute and a principal i...
... the upper limit of normal. Efficacy results in this group of 274 patients, which are the focus of the confirmatory AGENDA trial, are displayed in the table below. (The hazard ratios indicate that the addition of Genasense to DTIC was associated with a 42% reduction in the risk of disease progression and a...
Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
... that patients in this group achieved a significantly superior outcome (see table below). "Genasense plus dacarbazine yielded superior results in a large ra...4 patients (who are the focus of the new AGENDA trial) are displayed in the table below. The hazard ratios indicate that the addition of Genasense to DTIC wa...MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
...the use of teplizumab as an induction therapy in pancreatic islet cell transplantation. Additional information regarding the studies is listed in the table below. Teplizumab Clinical Trials Study Brief Description Additional Information Protege trial Global...Amicus Therapeutics Announces Second Quarter 2007 Financial Results
...rences between U.S. GAAP EPS, net loss, research and development and general and administrative and the corresponding non-GAAP amounts are itemized in table 2, and are due to: -- Pre-tax share-based compensation expense under SFAS 123R of $1.0 million (or $0.14 per share), primarily related to employe......results from the study will be presented in the future, as will data from the ongoing double-blind, placebo-controlled heterozygous FH study. table 1: ISIS 301012 in HoFH, Summary of Results Lipid values are presented in mg/dL and % change from baseline. Patient 1 ...
... 300 mg/week) than the 300 mg/week cohort. table 1: ISIS 301012 Coadministered with Statins, Summa...nalysis was 30 days post last dose, Day 59 table 2: ISIS 301012 Coadministered with Statins, Absol...nalysis was 30 days post last dose, Day 59 table 3: ISIS 301012 Coadministered with Statins, Patie...
...r 12 weeks of treatment, and SVR, defined as undetectable HCV RNA 24 weeks after the end of 48 weeks of treatment. Response rates are presented in the table below: HCV RNA Results Omega IFN + RBV Omega IFN Alone (LOQ= 50 IU/ml) N=67 N...
Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than Vaccines Used in Previous Years
...8% and 21%). table 1 THOSE WHO HAD FLU SHOTS AND THOSE WHO G... 15 table 2 HOW MANY OF THOSE WHO GOT OR DID NOT HAV... 24 table 3 THE EXPERIENCES OF THOSE WHO BELIEV...Other TagsPHASPHASPHASPHASPHASPHASVAMPHSVHSVOther Contentsadenovirusesadenomyosisadenovirusadenovirusadenovirusadenovirusadhesionadhesionadhesionadhesionadhesionadhesionadhesionadolescentsadolescentsadolescentsadolescentsadjustmentadjustmentadjustmentadjustmentadjustmentadjustmentadjustmentadjustmentadolescentadolescentadolescentadolescentadoptionadoptionadoption
(Date:3/11/2010)... Van Andel Research Institute (VARI) researchers have developed a new ... the prostate in relation to the development of cancer. ... cells depend on different factors to survive, which could aid ... cells when developing treatments. , Prostate cancer is the most ... new cases and more than 27,000 deaths reported in the ...
(Date:3/11/2010)... focus of their attention. All insects that undergo ... this group of insects. "With more than 800,000 ... in evolution," underlines project manager Beutel. , Besides ... of one order, it can be noticed that ... outstandingly multiform. "Often it serves as the only ...
(Date:3/11/2010)... Spanish . , Diet and aerobic exercise are ... but not for obese subjects that have developed the ... for Research in Biomedicine (IRB Barcelona) and Trinity College ... 25 years of age carry mitochondrial proteins and genes ... generating insulin resistance and a reduced response to physical ...
Breaking Biology News(10 mins):VAI researchers develop tool to help study prostate cancer 2Insects and sex: 'Educational help' from the museum 2New alterations found in young adults with type 2 diabetes 2Prostate Net Announces 3A Major Medical Education Initiative for Patients Caregivers and Healthcare Professionals 55139 1Prostate Net Announces 3A Major Medical Education Initiative for Patients Caregivers and Healthcare Professionals 55139 2Prostate Net Announces 3A Major Medical Education Initiative for Patients Caregivers and Healthcare Professionals 55139 3Advanced Instruments Introduces Next Generation Web Site 13665 1Advanced Instruments Introduces Next Generation Web Site 13665 2Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 1Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 2Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 3Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 4(Date:3/13/2010)... March 13 The American Association of Public Health Physicians submitted ... in response to their official stance concerning electronic cigarettes . They ... health the products could have in the future. , ... ... ...
(Date:3/13/2010)... a new report from The Digital Policy Council, examines how Web ... Government 2.0 where politics has a ‘human’ face and political views ... , ... Washington, DC (PRWeb) March 13, 2010 -- Real ... state around the world are using the World Wide Web to ...
(Date:3/13/2010)... professional and collegiate hockey players had abnormal hip and ... no symptoms of injury, according to a study presented ... Specialty Day in New Orleans, (March 13). The study,s ... to not depend excessively on imaging when diagnosing patients. ... MRI results are found incidentally in active roster hockey ...
(Date:3/12/2010)... , March 12 For Southern California residents who are looking ... as obese, who have a BMI of over 40, are prime candidates for Lap Band ... and gastric bypass surgery can lose anywhere from ten to twenty five pounds of ... ... ...
(Date:3/12/2010)... Tenn. , March 12 ... CYH ), its chairman, president and chief ... executive vice president and chief financial officer, ... Institutional Investor magazine as the number one ... the healthcare and managed care sectors. This is ...
Breaking Medicine News(10 mins):Health News:Electronic Cigarettes Are Tobacco Products, States AAPHP 2Health News:Electronic Cigarettes Are Tobacco Products, States AAPHP 3Health News:Electronic Cigarettes Are Tobacco Products, States AAPHP 4Health News:Digital Policy Council Urges Heads of State to Lead and Follow -- with Good Governance on the Net 2Health News:Digital Policy Council Urges Heads of State to Lead and Follow -- with Good Governance on the Net 3Health News:Digital Policy Council Urges Heads of State to Lead and Follow -- with Good Governance on the Net 4Health News:Digital Policy Council Urges Heads of State to Lead and Follow -- with Good Governance on the Net 5Health News:New study finds 70 percent of able-bodied hockey players have abnormal hip and pelvis MRIs 2Health News:Dr. Feiz (drfeiz.com) Asks: What Is Better for You? Lap Band Surgery/Realize Band Surgery or Gastric Bypass Surgery 2Health News:Dr. Feiz (drfeiz.com) Asks: What Is Better for You? Lap Band Surgery/Realize Band Surgery or Gastric Bypass Surgery 3Health News:Community Health Systems, Inc.'s Wayne T. Smith and Larry Cash Named America's Top Healthcare CEO and CFO 2[0] Electronic Cigarettes Are Tobacco Products, States AAPHP[0] Digital Policy Council Urges Heads of State to Lead and Follow -- with Good Governance on the Net[0] New study finds 70 percent of able-bodied hockey players have abnormal hip and pelvis MRIs[0] Dr. Feiz (drfeiz.com) Asks: What Is Better for You? Lap Band Surgery/Realize Band Surgery or Gastric Bypass Surgery[0] Community Health Systems, Inc.'s Wayne T. Smith and Larry Cash Named America's Top Healthcare CEO and CFO
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |